![](https://www.texasretina.com/wp-content/uploads/2022/06/Abbey-Ashkan-08-Blog-Head-Shot-1.jpg)
Posted On September 26, 2023 /
By Debbie Muse / Posted in Blog
Dr. Abbey Publishes Research on Effectiveness of a Long-acting Injectable Steroid for Patients with Cystoid Macular Edema After Vitrectomy
Long-acting injectable steroids have emerged as a new way to treat chronic intraocular inflammation and cystoid macular edema (CME) that reduces the treatment frequency and burden for retina patients. Texas Retina’s Ashkan
read more![](https://www.texasretina.com/wp-content/uploads/2018/07/David-Callanan-MD.jpg)
Posted On November 8, 2019 /
By Debbie Muse / Posted in Blog
David Callanan, MD, Presented Uveitis Clinical Trial Results at American Society of Retina Specialists 2019 Annual Meeting
Texas Retina Associates’ David Callanan, MD, presented the results of a clinical trial on a promising new treatment for chronic posterior segment uveitis at the American Society of Retina Specialists (ASRS) 2019
read more